Ai-Lin Deng

AI‑Driven Multi‑Omics Integrative Model for Predicting Tumor‑Specific Drug Responses

Precision oncology requires robust drug-response prediction because single biomarkers cannot fully explain therapeutic variation across tumors, cell lines, and drug structures. This study develops an AI-driven multi-omics model using GDSC, CCLE, DepMap, CTRP, and TCGA data, integrating mutation, copy-number variation,...